Investigation on the Management for Patients with Echinococcosis Treated with Albendazole - Three PLADs, China, 2019.

China CDC Weekly Pub Date : 2023-05-19 DOI:10.46234/ccdcw2023.083

Min Qin, Liying Wang, Ying Wang, Xu Wang, Jiaxi Lei, Xixi Cheng, Yu Feng, Yanyan Hou, Qian Wang, Chuizhao Xue, Laurent Gavotte, Roger Frutos

{"title":"Investigation on the Management for Patients with Echinococcosis Treated with Albendazole - Three PLADs, China, 2019.","authors":"Min Qin, Liying Wang, Ying Wang, Xu Wang, Jiaxi Lei, Xixi Cheng, Yu Feng, Yanyan Hou, Qian Wang, Chuizhao Xue, Laurent Gavotte, Roger Frutos","doi":"10.46234/ccdcw2023.083","DOIUrl":null,"url":null,"abstract":"What is already known about this topic?: In China, patients with echinococcosis receive complimentary healthcare services, such as medical treatment, diagnostic examinations, and follow-up care. Despite this, no studies have been conducted to assess the quality of patient management to date.What is added by this report?: This study reviewed the medical records of 899 patients who underwent albendazole treatment across 10 endemic counties. Out of 634 evaluable patient files, the proportion of patients with a ratio of actual follow-up and reexamination times to theoretical follow-up and reexamination times ≥0.8 were both low (21.92% and 23.19%, respectively).What are the implications for public health practices?: This study identified weaknesses and specific issues in patient management and proposed feasible recommendations to enhance patient file documentation, follow-up, and reexamination.","PeriodicalId":9867,"journal":{"name":"China CDC Weekly","volume":"5 20","pages":"437-441"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/61/60/ccdcw-5-20-437.PMC10236642.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"China CDC Weekly","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46234/ccdcw2023.083","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

What is already known about this topic?: In China, patients with echinococcosis receive complimentary healthcare services, such as medical treatment, diagnostic examinations, and follow-up care. Despite this, no studies have been conducted to assess the quality of patient management to date.

What is added by this report?: This study reviewed the medical records of 899 patients who underwent albendazole treatment across 10 endemic counties. Out of 634 evaluable patient files, the proportion of patients with a ratio of actual follow-up and reexamination times to theoretical follow-up and reexamination times ≥0.8 were both low (21.92% and 23.19%, respectively).

What are the implications for public health practices?: This study identified weaknesses and specific issues in patient management and proposed feasible recommendations to enhance patient file documentation, follow-up, and reexamination.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

阿苯达唑治疗棘球蚴病的临床疗效调查，中国，2019。

关于这个话题我们已经知道了什么?在中国，包虫病患者得到免费的医疗服务，如医疗、诊断检查和随访护理。尽管如此，迄今为止还没有研究对患者管理质量进行评估。这份报告增加了什么内容?本研究回顾了10个流行县接受阿苯达唑治疗的899例患者的医疗记录。在634份可评估患者档案中，实际随访及复查次数与理论随访及复查次数之比≥0.8的患者比例均较低(分别为21.92%和23.19%)。这对公共卫生实践有什么影响?本研究确定了患者管理的弱点和具体问题，并提出了可行的建议，以加强患者档案记录，随访和复查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

China CDC Weekly

自引率

0.00%

发文量